FDA Approved: LYSODREN — Supplemental Application (ESTEVE PHARMACEUTICALS, S.A.)

View source ↗

Summary

FDA approved a supplemental application for LYSODREN (mitotane) submitted by Esteve Pharmaceuticals, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• LYSODREN (MITOTANE)

Snippet

SUPPL AP for LYSODREN (MITOTANE)